MicroRNA-214 in Health and Disease.
Meer M J AminChristopher J TrevelyanNeil A TurnerPublished in: Cells (2021)
MicroRNAs (miRNAs) are endogenously expressed, non-coding RNA molecules that mediate the post-transcriptional repression and degradation of mRNAs by targeting their 3' untranslated region (3'-UTR). Thousands of miRNAs have been identified since their first discovery in 1993, and miR-214 was first reported to promote apoptosis in HeLa cells. Presently, miR-214 is implicated in an extensive range of conditions such as cardiovascular diseases, cancers, bone formation and cell differentiation. MiR-214 has shown pleiotropic roles in contributing to the progression of diseases such as gastric and lung cancers but may also confer cardioprotection against excessive fibrosis and oxidative damage. These contrasting functions are achieved through the diverse cast of miR-214 targets. Through silencing or overexpressing miR-214, the detrimental effects can be attenuated, and the beneficial effects promoted in order to improve health outcomes. Therefore, discovering novel miR-214 targets and understanding how miR-214 is dysregulated in human diseases may eventually lead to miRNA-based therapies. MiR-214 has also shown promise as a diagnostic biomarker in identifying breast cancer and coronary artery disease. This review provides an up-to-date discussion of miR-214 literature by describing relevant roles in health and disease, areas of disagreement, and the future direction of the field.
Keyphrases
- cell proliferation
- long non coding rna
- long noncoding rna
- coronary artery disease
- healthcare
- public health
- cardiovascular disease
- cell cycle arrest
- mental health
- gene expression
- cell death
- systematic review
- physical activity
- young adults
- machine learning
- signaling pathway
- body mass index
- left ventricular
- metabolic syndrome
- heat stress
- acute coronary syndrome
- cardiovascular events
- social media
- weight gain
- artificial intelligence
- nucleic acid
- childhood cancer